Versor Investments LP Makes New $278,000 Investment in Aspen Aerogels, Inc. $ASPN

Key Points

• Versor Investments LP has purchased 43,500 shares of Aspen Aerogels, valued at approximately $278,000, reflecting a small stake of 0.05% in the company.
• Institutional investors collectively own 97.64% of Aspen Aerogels, with significant increases in positions from firms like Allspring Global Investments and BNP Paribas Financial Markets.
• Aspen Aerogels reported a loss of ($0.04) EPS for the quarter, surpassing analyst estimates, while revenue decreased by 33.8% year-over-year to $78.02 million.

Versor Investments LP bought a new stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 43,500 shares of the construction company's stock, valued at approximately $278,000. Versor Investments LP owned approximately 0.05% of Aspen Aerogels at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. GAMMA Investing LLC raised its stake in shares of Aspen Aerogels by 1,998.7% in the first quarter. GAMMA Investing LLC now owns 3,316 shares of the construction company's stock valued at $210,000 after purchasing an additional 3,158 shares in the last quarter. Banque Cantonale Vaudoise acquired a new position in Aspen Aerogels during the first quarter worth $45,000. Exchange Traded Concepts LLC raised its stake in Aspen Aerogels by 460.4% during the first quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock worth $48,000 after acquiring an additional 6,109 shares in the last quarter. Sandia Investment Management LP acquired a new position in Aspen Aerogels during the fourth quarter worth $89,000. Finally, CWM LLC raised its stake in Aspen Aerogels by 2,137.9% during the first quarter. CWM LLC now owns 8,325 shares of the construction company's stock worth $53,000 after acquiring an additional 7,953 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ASPN has been the subject of several recent analyst reports. Canaccord Genuity Group dropped their price objective on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Oppenheimer lowered Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. Finally, Barclays lowered Aspen Aerogels from an "equal weight" rating to an "underweight" rating and increased their price objective for the stock from $7.00 to $16.00 in a research note on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $19.50.

Insider Buying and Selling

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the business's stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total transaction of $32,237.10. Following the completion of the sale, the chief accounting officer directly owned 19,879 shares of the company's stock, valued at approximately $145,315.49. The trade was a 18.16% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 4.30% of the stock is currently owned by insiders.

Aspen Aerogels Price Performance

Shares of ASPN stock traded down $0.09 during trading hours on Wednesday, hitting $7.04. 1,086,084 shares of the company's stock were exchanged, compared to its average volume of 2,655,628. The stock's 50-day moving average is $6.97 and its 200-day moving average is $6.70. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. The stock has a market cap of $579.40 million, a price-to-earnings ratio of -1.85 and a beta of 2.73. Aspen Aerogels, Inc. has a 52 week low of $4.16 and a 52 week high of $30.24.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its earnings results on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.08. The company had revenue of $78.02 million for the quarter, compared to analysts' expectations of $72.53 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The business's revenue for the quarter was down 33.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, research analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.